Recently becoming the sixth largest economy in the world, Brazil has relied, in large part, on its comparative advantages of resource extraction and agriculture. I am presenting about Brazil biotechnology evolution and challenges in a short and long term for those looking into this market. My latest accepted publication Biotechnology in Brazil: An Industry Overview at the Journal of Commercial Biotechnology will detail the state of the infrastructure and opportunities in that market. Akron has been active in that part of the world and we will share our experience in this meeting. SPI is a Science, Partnering and Investment Forum.Gateway for Global Life Sciences. May 21st-22nd Palm Beach Florida.